The Development of Epstein-Barr Virus Vaccines - Medical Intelligence Unit (Hardback)A. John Morgan
Hardback Published: 01/04/1995
- Not available
This text describes the development of the Epstein-Barr virus vaccine, which may ultimately eliminate or reduce the incidence of the cancers associated with this virus in humans. These include nasopharyngial carcinoma, endemic Burkitts lymphoma and certain lymphomas which occur with a relatively high frequency in immunosuppressed patients and AIDS sufferers. Such vaccines may also be deployed in the prevention of infectious mononucleosis. Several candidate vaccines based on recombinant viral envelope glycoproteins and a range of viral vectors are evaluated in a primate animal model of lymphoma induced by the virus.
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG